Sah DW - Search Results

1

Targeting the Nogo receptor to treat central nervous system injuries.

Lee DH, Strittmatter SM, Sah DW. Lee DH, et al. Among authors: sah dw. Nat Rev Drug Discov. 2003 Nov;2(11):872-8. doi: 10.1038/nrd1228. Nat Rev Drug Discov. 2003. PMID: 14668808 Review. No abstract available.

2

A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin.

Li W, Walus L, Rabacchi SA, Jirik A, Chang E, Schauer J, Zheng BH, Benedetti NJ, Liu BP, Choi E, Worley D, Silvian L, Mo W, Mullen C, Yang W, Strittmatter SM, Sah DW, Pepinsky B, Lee DH. Li W, et al. Among authors: sah dw. J Biol Chem. 2004 Oct 15;279(42):43780-8. doi: 10.1074/jbc.M401803200. Epub 2004 Aug 5. J Biol Chem. 2004. PMID: 15297463 Free article.

3

Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins.

Barton WA, Liu BP, Tzvetkova D, Jeffrey PD, Fournier AE, Sah D, Cate R, Strittmatter SM, Nikolov DB. Barton WA, et al. EMBO J. 2003 Jul 1;22(13):3291-302. doi: 10.1093/emboj/cdg325. EMBO J. 2003. PMID: 12839991 Free PMC article.

4

Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.

Li S, Liu BP, Budel S, Li M, Ji B, Walus L, Li W, Jirik A, Rabacchi S, Choi E, Worley D, Sah DW, Pepinsky B, Lee D, Relton J, Strittmatter SM. Li S, et al. Among authors: sah dw. J Neurosci. 2004 Nov 17;24(46):10511-20. doi: 10.1523/JNEUROSCI.2828-04.2004. J Neurosci. 2004. PMID: 15548666 Free PMC article.

5

Neurotrophic factors as novel therapeutics for neuropathic pain.

Sah DW, Ossipo MH, Porreca F. Sah DW, et al. Nat Rev Drug Discov. 2003 Jun;2(6):460-72. doi: 10.1038/nrd1107. Nat Rev Drug Discov. 2003. PMID: 12776221 Review.

6

TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.

Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, Thill G, Levesque M, Sah D, McCoy JM, Murray B, Jung V, Pepinsky RB, Mi S. Shao Z, et al. Neuron. 2005 Feb 3;45(3):353-9. doi: 10.1016/j.neuron.2004.12.050. Neuron. 2005. PMID: 15694322 Free article.

7

LINGO-1 negatively regulates myelination by oligodendrocytes.

Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. Mi S, et al. Nat Neurosci. 2005 Jun;8(6):745-51. doi: 10.1038/nn1460. Epub 2005 May 15. Nat Neurosci. 2005. PMID: 15895088

8

Glial cell line-derived neurotrophic factor (GDNF) receptor alpha-1 (GFR alpha 1) is highly selective for GDNF versus artemin.

Carmillo P, Dagø L, Day ES, Worley DS, Rossomando A, Walus L, Orozco O, Buckley C, Miller S, Tse A, Cate RL, Rosenblad C, Sah DW, Grønborg M, Whitty A. Carmillo P, et al. Among authors: sah dw. Biochemistry. 2005 Feb 22;44(7):2545-54. doi: 10.1021/bi049247p. Biochemistry. 2005. PMID: 15709767

9

GFRalpha3 is expressed predominantly in nociceptive sensory neurons.

Orozco OE, Walus L, Sah DW, Pepinsky RB, Sanicola M. Orozco OE, et al. Among authors: sah dw. Eur J Neurosci. 2001 Jun;13(11):2177-82. doi: 10.1046/j.0953-816x.2001.01596.x. Eur J Neurosci. 2001. PMID: 11422460

10

Gene therapy for neurological disorders: progress and prospects.

Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Deverman BE, et al. Among authors: sah dwy. Nat Rev Drug Discov. 2018 Sep;17(9):641-659. doi: 10.1038/nrd.2018.110. Epub 2018 Aug 10. Nat Rev Drug Discov. 2018. PMID: 30093643 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page